Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€132.40
14.01.21
€144.00
14.01.22
10.89%
15.01.22

buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€137.00
03.01.21
€150.00
03.01.22
50.37%
04.01.22

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€125.32
28.12.20
€140.00
28.12.21
20.17%
29.12.21

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€125.32
28.12.20
€140.00
28.12.21
20.17%
29.12.21

buy
Stryker Corp.

Start price
Target price
Perf. (%)
€198.16
05.02.21
€200.00
05.02.22
19.80%
28.12.21

Biogen Inc.

Start price
Target price
Perf. (%)
€243.10
18.10.21
€210.00
02.01.23
-12.53%
16.12.21

Could be worthwhile Investment >10% per year
Biogen Inc.

Start price
Target price
Perf. (%)
€243.10
18.10.21
€210.00
02.01.23
-12.53%
16.12.21

Could be worthwhile Investment >10% per year
Biogen Inc.

Start price
Target price
Perf. (%)
€243.10
18.10.21
€210.00
02.01.23
-12.53%
16.12.21

Could be worthwhile Investment >10% per year
Bayer AG

Start price
Target price
Perf. (%)
€47.84
12.10.21
€45.00
12.10.22
-8.10%
06.12.21

Could be worthwhile Investment >10% per year
Bayer AG

Start price
Target price
Perf. (%)
€47.84
12.10.21
€45.00
12.10.22
-8.10%
06.12.21

Could be worthwhile Investment >10% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
23.11.20
€555.00
23.11.21
29.97%
24.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
23.11.20
€555.00
23.11.21
29.97%
24.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
23.11.20
€555.00
23.11.21
29.97%
24.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.30
21.11.20
€40.00
21.11.21
45.99%
22.11.21

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.30
21.11.20
€40.00
21.11.21
45.99%
22.11.21

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€296.90
12.11.20
€400.00
12.11.21
35.67%
13.11.21

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€296.90
12.11.20
€400.00
12.11.21
35.67%
13.11.21

buy
Laboratory Corp. Of America (labcorp)

Start price
Target price
Perf. (%)
€175.00
23.10.20
€185.00
04.11.21
40.40%
05.11.21

buy
Align Technology

Start price
Target price
Perf. (%)
€377.00
23.10.20
€450.00
04.11.21
56.13%
05.11.21

buy
Align Technology

Start price
Target price
Perf. (%)
€377.00
23.10.20
€450.00
04.11.21
56.13%
05.11.21

buy
Align Technology

Start price
Target price
Perf. (%)
€377.00
23.10.20
€450.00
04.11.21
56.13%
05.11.21

buy
PerkinElmer Inc.

Start price
Target price
Perf. (%)
€105.00
20.10.20
€110.00
04.11.21
40.76%
05.11.21